Thank you for choosing TeleSlim Clinic in Illinois!
We accept cash-pay patients in Illinois — no insurance hassles.
Choose an option below to get started.
Zepbound remains a once-weekly injection (tirzepatide). However, Eli Lilly, the maker of Zepbound, received FDA approval on April 1, 2026 for Foundayo™ (orforglipron), a once-daily oral GLP-1 weight loss pill that can be taken any time of day, with or without food. If you were searching for “oral Zepbound,” Foundayo is almost certainly the medication you were looking for.
For years, the biggest question we heard from patients across Chicago and the western suburbs — from the Loop to Naperville to Oak Brook — was some version of: “Is there a pill version of Wegovy? I just can’t do injections.” As of January 2026, the answer is finally yes. The FDA approved the Wegovy® pill (oral semaglutide) in December 2025...
TeleSlim Clinic now offers a lower‑cost semaglutide option that makes Ozempic and Wegovy more attainable for many people in the Chicago area. For $349 per month, our subscription model aims to reduce financial hurdles while keeping physician oversight central to care.
The federal pricing initiative known as TrumpRx is changing how certain high cost anti obesity drugs are priced and distributed, opening clearer, lower cost routes for Chicago patients to access GLP 1 and GIP therapies.
In Chicago’s bustling health market, many people seek medical weight-loss solutions. Sadly, some providers promote compounded, unapproved injections of Semaglutide or Tirzepatide because they’re cheaper.
If you’ve been researching medical weight loss options in Chicago, you’ve likely come across tirzepatide, a game-changing injectable medication marketed under names like Zepbound and Mounjaro.
If you're researching weight loss medications in Chicago, you’ve probably come across two names over and over again.
If you're exploring medical weight loss options in Chicago, you've likely heard of semaglutide (brand names like Wegovy and Ozempic) and tirzepatide (Zepbound or Mounjaro).
In a world fascinated by celebrity weight loss stories-like the recent buzz around Kirsten Storms, Marcus Mumford, and Ginger Minj-many Chicagoans are asking a bigger question: If they can do it, why can’t I?
